The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17022791

Download in:

View as

General Info

PMID
17022791